V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.82 USD -3.75%
Market Cap: 76.3m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

VistaGen Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

VistaGen Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
V
VistaGen Therapeutics Inc
NASDAQ:VTGN
PP&E Net
$2.2m
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
27%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.2B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$2.5B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is VistaGen Therapeutics Inc's PP&E Net?
PP&E Net
2.2m USD

Based on the financial report for Jun 30, 2024, VistaGen Therapeutics Inc's PP&E Net amounts to 2.2m USD.

What is VistaGen Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
27%

Over the last year, the PP&E Net growth was -16%. The average annual PP&E Net growth rates for VistaGen Therapeutics Inc have been -15% over the past three years , -12% over the past five years , and 27% over the past ten years .

Back to Top